Indevus Pharmaceuticals Inc.

(NASDAQ:IDEV)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Cash Flow Statement
Cash At Beginning Of Period 71,142 71,142 71,142 71,142
Cash At End Of Period 131,306 52,624 60,765 82,300
Net Change In Cash And Cash Equivalents 60,164 -18,518 -10,377 11,158
Effect Of Exchange Rate Changes
Net Income Or Loss -65,551 -51,573 -32,609 -14,703
Cash From Operating Activities
Depreciation Expenses 4,581 3,327 2,002 983
Amortization Expenses 2,495 1,840 1,211 583
Amortization Of Intangibles Expenses
Deferred Income Taxes
Operating Gains Or Losses 1,165
Extraordinary Gains Or Losses
Increase Or Decrease In Receivables -7,263 -3,585 -4,488 -3,177
Increase Or Decrease In Inventories 1,818 -2,773 -3,742 -1,443
Increase Or Decrease In Prepaid Expenses 272 -1,293 808 -430
Increase Or Decrease In Other Current Assets 272 -1,293 808 -430
Increase Or Decrease In Payables
Increase Or Decrease In Other Current Liabilities 2,833 2,350 3,222 -1,799
Increase Or Decrease In Other Working Capital -7,863 -4,083 -6,690 -2,279
Other Non Cash Items 30,554 31,316 26,001 29,961
Net Cash From Continuing Operations 7,206 7,237 3,718 2,052
Net Cash From Discontinued Operations -29,753 -17,237 -10,567 9,748
Net Cash From Operating Activities
Cash From Investing Activities
Sale Of Property Plant And Equipment
Sale Of Long Term Investments
Sale Of Short Term Investments
Purchase Of Property Plant And Equipment -3,932 -3,822 -2,191 -451
Acquisitions
Purchase Of Long Term Investments
Purchase Of Short Term Investments
Other Investing Changes Net
Cash From Discontinued Investing Activities
Net Cash From Investing Activities -3,932 -3,822 -2,191 -451
Cash From Financing Activities
Issuance Of Debt 3,223 2,541 2,381 1,861
Issuance Of Capital Stock -10,075
Repayment Of Debt
Repurchase Of Capital Stock
Payment Of Cash Dividends
Net Other Financing Charges
Cash From Discontinued Financing Activities
Net Cash From Financing Activities 93,849 2,541 2,381 1,861